Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 346–360 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4264 CALR3 Gene Familial Hypertrophic Cardiomyopathy Type 19 Genetic Test This test identifies pathogenic variants in the CALR3 gene associated with Familial Hypertrophic Cardiomyopathy Type 19.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card Spot	3 - 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CALR3 gene", "Deletion/duplication analysis of the CALR3 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your cardiologist"] Indications ["Individuals with a family history of hypertrophic cardiomyopathy", "Individuals experiencing symptoms suggestive of hypertrophic cardiomyopathy", "Cascade screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 93680-8 ICD-10: I42.1, I42.8, Z15.89 Clinical summary This test identifies pathogenic variants in the CALR3 gene associated with Familial Hypertrophic Cardiomyopathy Type 19.
TEST-2175 Cancer Comprehensive Panel (Genetic Test) This test evaluates inherited genetic mutations in over 100 genes associated with increased cancer susceptibility.	Peripheral Whole Blood (3–5 mL in EDTA tube)	21–28 Days (3–4 Weeks)	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in cancer susceptibility genes", "Hereditary cancer risk"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication unless approved by your physician"] Indications ["Individuals with a personal or family history suggestive of hereditary cancer syndromes", "Risk assessment for individuals with specific cancer types (e.g., breast, ovarian, colorectal, prostate)", "Guiding personalized cancer screening and prevention strategies"] Measurement technique Confirm with laboratory Codes LOINC: 51966-8 ICD-10: Z15.09 Clinical summary This test evaluates inherited genetic mutations in over 100 genes associated with increased cancer susceptibility.
TEST-2884 CANT1 Gene Desbuquois Dysplasia Type 1 Genetic Test This test identifies pathogenic variants in the CANT1 gene associated with Desbuquois dysplasia type 1.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CANT1 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected Desbuquois dysplasia type 1", "Differential diagnosis of skeletal dysplasias"] Measurement technique Confirm with laboratory Codes LOINC: 94233-4 ICD-10: Q77.8 Clinical summary This test identifies pathogenic variants in the CANT1 gene associated with Desbuquois dysplasia type 1.
TEST-5192 CAPN1 Gene Sequencing (Muscular-Skeletal Disorders) Test This genetic test evaluates the CAPN1 gene for pathogenic variants associated with neuromuscular disorders.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAPN1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Provide a complete clinical history", "Provide family pedigree", "Prior genetic counseling is strongly recommended"] Indications ["Suspected hereditary spastic paraplegia", "Suspected limb-girdle muscular dystrophy", "Diagnostic confirmation of CAPN1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21613-4 ICD-10: G71.0, G11.4 Clinical summary This genetic test evaluates the CAPN1 gene for pathogenic variants associated with neuromuscular disorders.
TEST-4812 CAPN3 Gene Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A) Next-Generation Sequencing DNA Test This test analyzes the CAPN3 gene to identify pathogenic variants associated with Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A). It detects mutations responsible for a progressiv...	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAPN3 gene", "Full coding region analysis of CAPN3"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Individuals with clinical suspicion of LGMD2A", "Family history of LGMD2A", "Carrier screening in consanguineous families"] Measurement technique Confirm with laboratory Codes LOINC: 81644-7 ICD-10: G71.09, Z13.71, Z31.430 Clinical summary This test analyzes the CAPN3 gene to identify pathogenic variants associated with Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A). It detects mutations responsible for a progressive muscle-wasting disorder.
TEST-5162 CAPN3 Gene Limb‑Girdle Muscular Dystrophy Type 2A (LGMD2A) Genetic Test This genetic test identifies pathogenic variants within the CAPN3 gene, which are responsible for causing Limb-Girdle Muscular Dystrophy Type 2A.	Whole Blood (EDTA) – 5 mL	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAPN3 gene"] Parameters [] Preparation [] Indications ["Confirming clinical suspicion of LGMD2A", "Carrier screening", "Family planning decisions"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.0 Clinical summary This genetic test identifies pathogenic variants within the CAPN3 gene, which are responsible for causing Limb-Girdle Muscular Dystrophy Type 2A.
TEST-4471 Cardiology NGS Genetic Panel Test This test evaluates genetic variations in over 200 genes linked to inherited cardiovascular conditions.	Whole blood (Peripheral)	3–4 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by your physician"] Indications ["Assessment of risk for inherited cardiomyopathies", "Evaluation of familial hypercholesterolemia", "Screening for long QT syndrome", "Investigation of unexplained sudden cardiac death in family"] Measurement technique Confirm with laboratory Codes LOINC: 90270-6 ICD-10: Z13.6 Clinical summary This test evaluates genetic variations in over 200 genes linked to inherited cardiovascular conditions.
TEST-1741 Cardiomyopathy Gene Panel Test This test evaluates for genetic variants in over 70 genes associated with inherited cardiomyopathies using Next-Generation Sequencing.	Peripheral blood, amniotic fluid, chorionic villi	4–6 Weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in >70 cardiomyopathy-associated genes", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required for blood samples", "Follow specific instructions for prenatal specimens (amniotic fluid, CVS)"] Indications ["Individuals with a family history of cardiomyopathy", "Patients with unexplained heart failure", "Individuals with sudden cardiac death at a young age", "Surgical clearance", "Pregnancy", "Pre-travel screening"] Measurement technique Confirm with laboratory Codes LOINC: 95007-1 ICD-10: I42.9, I42.0, I42.1, I42.2 Clinical summary This test evaluates for genetic variants in over 70 genes associated with inherited cardiomyopathies using Next-Generation Sequencing.
TEST-4490 CASK Gene (FG Syndrome Type 4) Genetic Test This test evaluates the CASK gene for mutations associated with FG syndrome type 4, an X-linked neurodevelopmental disorder.	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASK gene coding region", "CASK gene splice sites"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Stay well hydrated before the appointment."] Indications ["Suspected FG syndrome type 4", "X-linked neurodevelopmental disorder investigation"] Measurement technique Confirm with laboratory Codes LOINC: 90268-4 ICD-10: Q87.8 Clinical summary This test evaluates the CASK gene for mutations associated with FG syndrome type 4, an X-linked neurodevelopmental disorder.
TEST-4775 CASK Gene Genetic Test for Mental Retardation & Microcephaly with Pontocerebellar Hypoplasia This test identifies pathogenic variants in the CASK gene, which are associated with X-linked intellectual disability, microcephaly, and pontocerebellar hypoplasia.	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3 – 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CASK gene", "Single nucleotide variants", "Small insertions and deletions", "Copy-number variants"] Parameters [] Preparation [] Indications ["Individuals with unexplained intellectual disability, developmental delay, microcephaly, cerebellar hypoplasia, or pontocerebellar hypoplasia.", "At-risk family members of a proband with a known CASK pathogenic variant."] Measurement technique Confirm with laboratory Codes LOINC: 81261-4 ICD-10: Q04.8, Q02, F70 Clinical summary This test identifies pathogenic variants in the CASK gene, which are associated with X-linked intellectual disability, microcephaly, and pontocerebellar hypoplasia.
TEST-5374 CASP10 Gene Autoimmune Lymphoproliferative Syndrome Type 2A Genetic Test This genetic test identifies pathogenic variants in the CASP10 gene associated with Autoimmune Lymphoproliferative Syndrome type 2A (ALPS-2A).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASP10 gene pathogenic variants", "Single-nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["No fasting required", "Continue all regular medications unless otherwise instructed by the genetic counselor"] Indications ["Suspected Autoimmune Lymphoproliferative Syndrome type 2A", "Family history of ALPS", "Unexplained autoimmune cytopenias"] Measurement technique Confirm with laboratory Codes LOINC: 94085-1 ICD-10: D47.29 Clinical summary This genetic test identifies pathogenic variants in the CASP10 gene associated with Autoimmune Lymphoproliferative Syndrome type 2A (ALPS-2A).
TEST-5331 CASP8 Gene Autoimmune Lymphoproliferative Syndrome Type 2B Genetic Test This test identifies pathogenic variants in the CASP8 gene associated with Autoimmune Lymphoproliferative Syndrome Type 2B (ALPS-2B).	Peripheral whole blood (EDTA)	3–4 Weeks (expedited 2‑week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASP8 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "≥99.9%"}, {"name": "Analytical Specificity", "reference_range": "≥99.9%"}, {"name": "Variant Types Detected", "reference_range": "SNVs, indels, CNVs"}] Preparation ["No fasting required", "Formal genetic counseling session mandatory", "Detailed pedigree chart required", "Complete clinical history required", "List all medications/supplements", "Avoid blood transfusions for at least 2 weeks prior"] Indications ["Unexplained lymphoproliferation", "Autoimmune cytopenias", "Family history of ALPS"] Measurement technique Confirm with laboratory Codes LOINC: 88151-2 ICD-10: D89.82, Z13.5 Clinical summary This test identifies pathogenic variants in the CASP8 gene associated with Autoimmune Lymphoproliferative Syndrome Type 2B (ALPS-2B).
TEST-3734 CASR Gene Hypocalcemia, Autosomal Dominant with Bartter Syndrome NGS Test This test sequences the CASR gene to detect activating mutations causing autosomal dominant hypocalcemia with Bartter syndrome.	Whole Blood, Extracted DNA, FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASR gene sequence", "Pathogenic variants in CASR gene"] Parameters [] Preparation ["No fasting required", "Genetic counselling prior to sample collection"] Indications ["Suspected autosomal dominant hypocalcemia", "Family history of hypocalcemia", "Need for precise subclassification of calcium disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94726-9 ICD-10: E83.51 Clinical summary This test sequences the CASR gene to detect activating mutations causing autosomal dominant hypocalcemia with Bartter syndrome.
TEST-3776 CASR Gene Hypocalciuric Hypercalcemia Type 1 Genetic Test This test identifies genetic variants in the CASR gene associated with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1). It helps confirm the diagnosis and differentiate FHH1 fro...	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CASR gene", "Calcium metabolism regulation"] Parameters [{"name": "Genomic Coverage", "reference_range": "Full coding region, splice sites, and selected deep intronic regions; variant detection down to 5% allele frequency"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with bioinformatic annotation and ACMG/AMP variant classification"}, {"name": "Turnaround Time", "reference_range": "3–4 weeks with expedited clinical reporting"}] Preparation ["No specific fasting required", "Do not discontinue calcium-regulating medications without physician instruction"] Indications ["Diagnosis of Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)", "Differentiation from primary hyperparathyroidism", "Cascade screening of family members"] Measurement technique Confirm with laboratory Codes LOINC: 74823-8 ICD-10: E83.52 Clinical summary This test identifies genetic variants in the CASR gene associated with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1). It helps confirm the diagnosis and differentiate FHH1 from other causes of hypercalcemia.
TEST-6042 CAT Gene Acatalasemia Genetic Test This test evaluates the entire CAT gene for pathogenic variants associated with Acatalasemia (Catalase Deficiency).	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAT gene", "Catalase enzyme activity (indirectly via genetic analysis)"] Parameters [] Preparation ["No fasting required", "No medication changes needed", "Avoid blood transfusions for 2 weeks prior"] Indications ["Suspected Acatalasemia based on clinical presentation", "Family history of Acatalasemia", "Carrier screening for family members"] Measurement technique Confirm with laboratory Codes LOINC: 101826-7 ICD-10: E88.0, Z15.89, Z13.79 Clinical summary This test evaluates the entire CAT gene for pathogenic variants associated with Acatalasemia (Catalase Deficiency).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories